Life Science Summit 2026
BioStock is delighted to welcome you to the 9th annual BioStock Summit, the premier event bringing the Nordic life science community together for two inspiring days of innovation, collaboration, and investment opportunities.
The BioStock Summit is the essential meeting place where early- to growth-phase companies showcase their groundbreaking research and innovative solutions to a dedicated audience of Swedish and international investors.
Discover the next generation of life science leaders, highlighting the Nordic region’s scientific expertise and innovative strength across biotech, medtech, and pharmaceuticals. This is your chance to identify high-potential investments and forge meaningful partnerships that will drive the future of healthcare.
ON STAGE
Event Partners
Speakers
Svana Gunnarsdóttir
Co-founder & Managing Partner
Frumtak Ventures
Anesa Mulabecirovic Sahnoun
Portfolio Manager
DNB Fund Women’s Health
Pekka Simula
Partner
Innovestor
Andreas Dirnagl
Senior Adviser
Healthcare DNB Bank
Stephan Christgau
Founding Partner
Eir Ventures
Martin Jönsson
CEO
AlzeCure
Farzad Abdi-Dezfuli
Partner, Life Sciences
Sarsia
Thomas Thestrup
Managing Partner
Fresenius Ventures
Karl Tobieson
CEO
Linc
Kristofer Klerfalk
Managing Partner
Life Science Invest
Fredrik Meurling
CEO
Yazen
Eva Dahlén
Global Evaluation Director, Search & Evaluation
Novo Nordisk
Cecilia Stureborg von Schéele
CFO
Flerie
Renée Lucander
CEO
Hansa Biopharma
Laura Bejtulai
Linda Spahiu Elvesjö
Principal
Sound Bioventures
Julie Waras Brogren
CEO
Gedea Biotech
Lao Saal
Medical Director at DoMore Diagnostics
Founder at SAGA Diagnostics
Camilla Harder Hartvig
Group Leader Womens Health and Lifescience
Angella Invest
Georgina Askeland
Principal
Hadean Ventures
Claus Henrik Johansen
CEO
Global Health Invest
Mads Tang-Christensen
CSO
Antag Therapeutics
Anna Gran
Managing Director
Askel
Company showcases
Experience dynamic, concise presentations from pioneering life science innovators, showcasing cutting-edge advancements and transformative trends shaping the industry’s future. Engage directly with these trailblazers in interactive Q&A sessions, gaining exclusive insights to inform your strategic decisions. Don’t miss this premier opportunity to connect, learn, and invest in the next wave of life science innovation.
The Obesity Race 2.0: Beyond the Scale
Strategic Money: Building a €200m Venture Fund From Scratch.
Fresenius, one of the world’s leading healthcare groups, has launched its own venture arm, Fresenius Ventures. In this session, BioStock’s Jonas Söderström talks to Thomas Thestrup, Managing Director of Fresenius Ventures, about what it takes to build a €200m fund from the ground up.
Backed by a global healthcare group, Fresenius Ventures can offer start-ups more than capital: industry expertise, networks and a route to the market. Thomas shares his background, the fund’s strategy, and what he is looking for in future investments.
The Women’s Health Investment Revolution: Unlocking a Nordic opportunity.
The Nordic region leads globally in gender equality, public health data access, and innovation capacity, yet women’s health remains an underfunded and underserved market even here. This panel explores how targeted investment across biotech, medtech, and digital health can transform women’s health into a high-growth Nordic industry while closing long-standing care gaps.
See the full Agenda
Venue
We are thrilled to host this year’s conference at the Elite Hotel Ideon, located right in the heart of Lund’s vibrant Ideon Science Park. Situated inside the iconic Ideon Gateway building, the tallest landmark in Lund, the venue perfectly blends innovative design with top-tier professional facilities.
Discounted hotel rooms are available for conference attendees looking to stay on-site, contact us for booking codes.
Testimonials
The venue and organization was top tier, quite impressed. Great pitches and generous pauses for mingling with a highly relevant audience
Great presentations by interesting companies and investors, nice networking opportunities.
Professional, an event that will grow due to arranger/host qualities
About our event partners
DNB Carnegie | Back Bay
DNB Carnegie | Back Bay is a unique integrated strategy and corporate and investment banking solution for global and emerging life science and healthcare companies.
We combine scientific and strategic expertise with financing origination and execution to support healthcare companies of all sizes through each stage of growth—from chemistry to commercialization. Learn more and subscribe for our market updates: www.bblsa.com/dnb-carnegie-back-bay-partnership
Nasdaq
With more than 90 pct. of all US biotech, pharma & life science companies listed on Nasdaq, we know how to match savvy investors with trail-blazing inventors.
We are here to support your ideas and the next steps to a public offering that keeps you in control while raising capital to ignite your ambition. By the way, if you want to keep your ambition closer to home, Nasdaq in the Nordic is the leading hub for listed biotech and health care companies in Europe, with strong support from investors and innovation communities across the region.
How to join the Nasdaq family? – Read more here.
Great and exciting ideas arise when people meet. We believe in bringing together individuals and organisations with similar values and objectives. This is why we founded Haeger & Carlsson back in 2015.
We create the conditions required for individuals to become successful, and in such way contribute to the company’s success.
With a transparent and well-defined process and an industry leading network, we proud ourselves of being one of the leading recruitment companies in life science in the Nordic region.
